AtriCure Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
26,211.00
59,649.00
34,578.00
44,009.00
34,451.00
124,402
Total Accounts Receivable
13,652.00
17,558.00
19,409.00
21,094.00
23,083.00
25,195
Inventories
10,214.00
14,257.00
17,659.00
17,660.00
22,451.00
22,484
Other Current Assets
2,410.00
2,044.00
3,106.00
2,954.00
2,273.00
2,592
Total Current Assets
52,487.00
93,508.00
74,752.00
85,717.00
82,258.00
174,673
Net Property, Plant & Equipment
5,643.00
11,552.00
31,279.00
29,995.00
28,749.00
27,080
Total Investments and Advances
7,914.00
8,894.00
7,706.00
3,000.00
-
-
Intangible Assets
45,685.00
44,264.00
159,032.00
157,388.00
156,021.00
154,511
Other Assets
218.00
186.00
323.00
321.00
676.00
495
Total Assets
111,947.00
158,404.00
273,092.00
276,421.00
267,704.00
356,759
ST Debt & Current Portion LT Debt
2,038.00
40.00
450.00
1,688.00
561.00
Accounts Payable
8,605.00
7,621.00
12,744.00
10,673.00
12,431.00
Income Tax Payable
546.00
-
-
-
-
Other Current Liabilities
15,524.00
17,982.00
18,394.00
16,467.00
18,911.00
Total Current Liabilities
26,713.00
25,643.00
31,588.00
28,828.00
31,903.00
Long-Term Debt
4,412.00
74.00
13,710.00
37,205.00
36,861.00
Other Liabilities
8,218.00
149.00
41,109.00
41,946.00
37,774.00
Total Liabilities
39,343.00
25,866.00
86,407.00
107,979.00
106,538.00
Common Equity (Total)
72,604.00
132,538.00
186,685.00
168,442.00
161,166.00
Total Shareholders' Equity
72,604.00
132,538.00
186,685.00
168,442.00
161,166.00
Total Equity
72,604.00
132,538.00
186,685.00
168,442.00
161,166.00
Liabilities & Shareholders' Equity
111,947.00
158,404.00
273,092.00
276,421.00
267,704.00

About AtriCure

View Profile
Address
7555 Innovation Way
Mason Ohio 45069
United States
Employees -
Website http://www.atricure.com
Updated 07/08/2019
AtriCure, Inc. engages provision of treatment of atrial fibrillation and left atrial appendage. It operates through the following geographical segments: United States, Europe, Asia, and Other International. Its product, Isolator Synergy Ablation System, is a surgical device that treats the persistent longstanding persistent forms of atrial fibrillation in patients undergoing certain open concomitant procedures.